Ann: Investor Presentation, page-10

I Just heard the interview and Carrick reinforces all the positivity that surrounded the device after the study results. It is a shame that we are in a lack lustre market because i am sure that this would easily be a 50 cent stock in a more buoyant market.
Carrick also referred again to the possible application in Alzheimer's and other neurological based conditions, so the potential of this device is simply enormous.
Once researchers start applying the science to other disease states, there may a huge flurry of data come through as to its future applications outside of autism.
I know there are a lot of biotech's out there with potential but surely Neurotech are now much closer to realizing their potential than most other Biotech stocks on the ASX.
GLTA